Losing just 6.5% of body weight in midlife may lower later risk of disease and premature death, new research shows.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Asthma and cardiovascular ...

Mortality risk was 34% lower among patients who underwent spirometry when initiating medication for a chronic respiratory condition.

Losing just 6.5% of body weight in midlife may lower later risk of disease and premature death, new research shows.

The U.S. Food and Drug Administration (FDA) has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with chronic obstructive pulmonary disease (COPD) with ...

Medically reviewed by Leigh Weddle, PharmD Serrapeptase, or serratiopeptidase, is an enzyme made naturally in the intestines ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Learn what hospice is and how it can improve the quality of life. Discover its myths, truths, and how it can provide comfort ...

A recent study indicated that losing 6.5% of body weight without any weight loss medicines and surgery in midlife may reduce ...